Page last updated: 2024-11-04

sb 202190 and Thrombosis

sb 202190 has been researched along with Thrombosis in 1 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lidington, EA1
Haskard, DO1
Mason, JC1

Other Studies

1 other study available for sb 202190 and Thrombosis

ArticleYear
Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury.
    Blood, 2000, Oct-15, Volume: 96, Issue:8

    Topics: CD55 Antigens; Cells, Cultured; Complement Activation; Complement System Proteins; Endothelial Growt

2000